Addex Therapeutics Ltd. (ADXN)
Market Closed
15 Oct, 08:00 PM
$
3. 02
+0.37
+13.958%
Pre Market
$
+0.11 +3.6424% 3. 13
3.92M Market Cap
- P/E Ratio
- Div Yield
36,186 Volume
0 Eps
$ 2.65
Previous Close Want to track ADXN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Addex Therapeutics Ltd. (ADXN) Statistics
Valuation metrics
Market Cap 3.92M
Enterprise value 2.83M
Trailing P/E (ttm) -0.49
Forward P/E -140.6
PEG ratio -0.02
Price/Sales (ttm) 55.77
Price/Book (mrq) 2.13
Enterprise Value/Revenue 44.85
Enterprise Value/EBITDA -0.82
Overview
Shares outstanding 116.57M
Float 92.72M
Shares short 6.75K
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 7.01K
Average volume (90 days) 146.26K
Price summary
52-Week low 2.56
52-Week high 11.97
Beta 1.86
50-Day moving average 3.49
200-Day moving average 5.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 23 Oct 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Sep 2025
Profitability
Profit margin -108.75%
Operating margin -41.15%
Operational effectiveness
Return on assets -1.98%
Return on equity -1.73%
Income Statement
Revenue (ttm) 203.7K
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -0.15%
Gross profit (ttm) -675.4K
EBITDA -3.16M
Net income to common (ttm) -7.96M
Diluted EPS (ttm) -4.73
Quarterly earnings growth (yoy) -0.56%
Balance Sheet
Total cash (mrq) 2.81M
Total cash per share (mrq) 0.53
Total debt (mrq) 46.96K
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 0.76%
Book value per share (mrq) 1.31
Cash Flow
Cash flow statement -2.02M
Levered free cash flow (LFCF) -770.72K
2026 © Marketlog. All Rights Reserved.
